Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Kite Pharma Inc (KITE) a Good Buy?

Page 1 of 2

How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don’t always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let’s take a look at the recent hedge fund activity surrounding Kite Pharma Inc (NASDAQ:KITE).

Hedge fund interest in Kite Pharma Inc (NASDAQ:KITE) shares was flat at the end of last quarter. This is usually a negative indicator. At the end of this article we will also compare KITE to other stocks including Puma Biotechnology Inc (NYSE:PBYI), United Natural Foods, Inc. (NASDAQ:UNFI), and Sinclair Broadcast Group, Inc. (NASDAQ:SBGI) to get a better sense of its popularity.

Follow Kite Pharma Inc. (NASDAQ:KITE)
Trade (NASDAQ:KITE) Now!

Keeping this in mind, let’s take a gander at the new action encompassing Kite Pharma Inc (NASDAQ:KITE).

What does the smart money think about Kite Pharma Inc (NASDAQ:KITE)?

Heading into Q4, a total of 22 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 0% from the second quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were upping their stakes considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Viking Global, managed by Andreas Halvorsen, holds the number one position in Kite Pharma Inc (NASDAQ:KITE). Viking Global has a $137.7 million position in the stock, comprising 0.5% of its 13F portfolio. The second largest stake is held by Wildcat Capital Management, managed by Leonard A. Potter, which holds a $131.3 million position; the fund has 49% of its 13F portfolio invested in the stock. Some other hedge funds and institutional investors that are bullish encompass Christopher James’s Partner Fund Management, Oleg Nodelman’s EcoR1 Capital and Guy Shahar’s DSAM Partners.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!